| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | Aug 5, 2025 | Verona Pharma plc | CFO | Sell | 40.0 | -208,912 | -1.65% | ✓ | $2.7M |
| Jul 7, 2025 | Jul 9, 2025 | Verona Pharma plc | CFO | Sell | 40.0 | -90,320 | -0.72% | ✗ | $1M |
| Jun 11, 2025 | Jun 13, 2025 | Verona Pharma plc | CFO | Sell | 32.5 | -400,000 | -3.15% | ✓ | $4.6M |
| May 27, 2025 | May 29, 2025 | Verona Pharma plc | CFO | Sell | 32.5 | -400,000 | -3.06% | ✓ | $3.7M |
| May 1, 2025 | May 5, 2025 | Verona Pharma plc | CFO | Sell | 38.8 | -587,008 | -1.45% | ✓ | $5.3M |
| Apr 29, 2025 | May 1, 2025 | Verona Pharma plc | CFO | Sell | 45.0 | -90,360 | -0.67% | ✓ | $811.4K |
| Feb 1, 2025 | Feb 4, 2025 | Verona Pharma plc | CFO | Sell | 70.0 | +33,112 | 0.25% | ✗ | $1.2M |
| Dec 4, 2024 | Dec 6, 2024 | Verona Pharma plc | CFO | Sell | 27.5 | -881,960 | -6.22% | ✓ | $4.4M |
| Nov 27, 2024 | Dec 2, 2024 | Verona Pharma plc | CFO | Sell | 45.0 | -113,240 | -0.79% | ✓ | $566.8K |
| Nov 25, 2024 | Nov 26, 2024 | Verona Pharma plc | CFO | Sell | 57.5 | -2,400 | -0.02% | ✓ | $12K |
| Nov 11, 2024 | Nov 13, 2024 | Verona Pharma plc | CFO | Sell | 57.5 | -2,400 | -0.02% | ✓ | $12K |
| Nov 1, 2024 | Nov 5, 2024 | Verona Pharma plc | CFO | Sell | 45.0 | -129,672 | -0.90% | ✓ | $568.4K |
| Oct 30, 2024 | Nov 1, 2024 | Verona Pharma plc | CFO | Sell | 95.0 | +754,048 | 5.52% | ✗ | $1M |
| Oct 24, 2024 | Oct 25, 2024 | Verona Pharma plc | CFO | Sell | 42.5 | -144,560 | -1.05% | ✓ | $632.8K |
| Oct 18, 2024 | Oct 22, 2024 | Verona Pharma plc | CFO | Sell | 32.5 | -525,768 | -3.67% | ✓ | $2.3M |
| Sep 11, 2024 | Sep 13, 2024 | Verona Pharma plc | CFO | Sell | 32.5 | -600,000 | -4.02% | ✓ | $2.3M |
| Aug 12, 2024 | Aug 14, 2024 | Verona Pharma plc | CFO | Sell | 36.3 | -400,000 | -2.61% | ✓ | $1.3M |
| Aug 7, 2024 | Aug 9, 2024 | Verona Pharma plc | CFO | Sell | 90.0 | +485,200 | 3.27% | ✗ | $824.8K |
| Aug 1, 2024 | Aug 5, 2024 | Verona Pharma plc | CFO | Sell | 42.5 | -88,544 | -0.59% | ✗ | $250.8K |
| May 1, 2024 | May 3, 2024 | Verona Pharma plc | CFO | Sell | 45.0 | -88,544 | -0.59% | ✗ | $171K |
| Feb 1, 2024 | Feb 5, 2024 | Verona Pharma plc | CFO | Sell | 37.5 | -480,664 | -3.10% | ✗ | $1.1M |
| Nov 1, 2023 | Nov 3, 2023 | Verona Pharma plc | CFO | Sell | 37.5 | -809,008 | -4.96% | ✗ | $1.4M |
| Aug 3, 2023 | Aug 7, 2023 | Verona Pharma plc | CFO | Sell | 42.5 | -275,888 | -1.75% | ✓ | $693.9K |
| Aug 1, 2023 | Aug 3, 2023 | Verona Pharma plc | CFO | Sell | 42.5 | -179,648 | -1.12% | ✓ | $474.9K |
| May 1, 2023 | May 3, 2023 | Verona Pharma plc | CFO | Sell | 36.3 | -455,528 | -2.77% | ✓ | $1.2M |
| Feb 1, 2023 | Feb 3, 2023 | Verona Pharma plc | CFO | Sell | 36.3 | -413,168 | -2.45% | ✓ | $1.1M |
| Dec 20, 2022 | Dec 21, 2022 | Verona Pharma plc | CFO | Sell | 32.5 | -600,000 | -3.44% | ✓ | $1.3M |
| Nov 1, 2022 | Nov 3, 2022 | Verona Pharma plc | CFO | Sell | 38.8 | -468,016 | -2.61% | ✓ | $749.8K |
| Aug 9, 2022 | Aug 11, 2022 | Verona Pharma plc | CFO | Sell | 32.5 | -600,000 | -4.02% | ✓ | $1.1M |
| Aug 1, 2022 | Aug 3, 2022 | Verona Pharma plc | CFO | Sell | 35.0 | -468,024 | -3.04% | ✓ | $315.1K |
| May 3, 2022 | May 5, 2022 | Verona Pharma plc | CFO | Sell | 56.3 | -12,512 | -0.08% | ✓ | $6.2K |
| May 1, 2022 | May 3, 2022 | Verona Pharma plc | CFO | Sell | 42.5 | -432,128 | -2.73% | ✗ | $225.8K |
| Feb 1, 2022 | Feb 3, 2022 | Verona Pharma plc | CFO | Sell | 45.0 | -164,960 | -1.03% | ✓ | $231.7K |
| Nov 1, 2021 | Nov 3, 2021 | Verona Pharma plc | CFO | Sell | 38.8 | -465,264 | -2.83% | ✓ | $297.8K |
| Aug 1, 2021 | Aug 3, 2021 | Verona Pharma plc | CFO | Sell | 38.8 | -465,256 | -2.75% | ✓ | $365K |
| May 3, 2021 | May 5, 2021 | Verona Pharma plc | CFO | Sell | 20.0 | -2,132,864 | -11.19% | ✓ | $1.9M |
| Mar 1, 2021 | Mar 3, 2021 | Verona Pharma plc | CFO | Sell | 53.8 | -26,728 | -0.14% | ✓ | $30.6K |